Benzinga | May 5, 2021 06:43AM EDT

SVB Leerink Maintains Outperform on Exact Sciences, Lowers Price Target to $170

SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $180 to $170.